Health Care·Biotechnology·$28.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.51 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.51 | N/A | N/A |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed caution regarding future performance without offering specific guidance. They emphasized the need for operational improvements.
Management did not provide specific guidance for the upcoming quarters.
The company is focusing on operational improvements and cost management.
Natera's earnings report showed a loss per share of $0.51, which may raise concerns among investors about the company's profitability. The stock reacted negatively, declining by 1.39%. The lack of revenue details and guidance could lead to uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
DIAMONDBACK ENERGY I
Nov 6, 2017